A phase II randomized, open label study of sipuleucel-T versus sipuleucel-T and tasquinimod in patients with metastatic castrate-resistant prostate cancer (CRPC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS5110-TPS5110
Author(s):  
Roberto Pili
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

scholarly journals Openact: Phase 2, Open-Label Study of Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer (MCRPC)

2012 ◽  
Vol 23 ◽  
pp. ix311
Author(s):  
J. Corman ◽  
N. Dawson ◽  
S. Hall ◽  
C. Nabhan ◽  
A. Ferrari ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase 2 ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant

A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential enzalutamide in metastatic castration-resistant prostate cancer (mCRPC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e16071-e16071 ◽  
Author(s):  
David I. Quinn ◽  
Daniel Peter Petrylak ◽  
Christopher Michael Pieczonka ◽  
Andrew Sandler ◽  
Todd DeVries ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Castration Resistant Prostate Cancer ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Castration Resistant ◽  
Randomized Phase Ii

scholarly journals A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy

2016 ◽  
Vol 23 (8) ◽  
pp. 1974-1980 ◽  
Author(s):  
Rashid K. Sayyid ◽  
Andrew Evans ◽  
Karen Hersey ◽  
Ranjena Maloni ◽  
Antonio Hurtado-Coll ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Phase Ii ◽  
Lhrh Agonist ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

PD37-04 A PHASE II, RANDOMIZED, OPEN LABEL STUDY OF NEOADJUVANT DEGARELIX VERSUS LHRH AGONIST IN PROSTATE CANCER PATIENTS PRIOR TO RADICAL PROSTATECTOMY

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Rashid Sayyid ◽  
Martin Gleave ◽  
Karen Hersey ◽  
Ranjena Maloni ◽  
Antonio Hurtado-Coll ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Phase Ii ◽  
Lhrh Agonist ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study

BioDrugs ◽  
2021 ◽  
Vol 35 (3) ◽  
pp. 325-336
Author(s):  
Irene Marafini ◽  
Carmine Stolfi ◽  
Edoardo Troncone ◽  
Elisabetta Lolli ◽  
Sara Onali ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase Ii ◽  
Induction Therapy ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer

2010 ◽  
Vol 6 (4) ◽  
pp. 292-297 ◽  
Author(s):  
Paul L DE SOUZA ◽  
Scott NORTH ◽  
Graeme B BOLGER ◽  
Harris SPIRIDONIDIS ◽  
Robert LIM ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Castrate Resistant Prostate Cancer ◽  
Castrate Resistant
Sign in / Sign up

Export Citation Format

Share Document